4.8 Article

Neonatal lethality in transgenic mice expressing prion protein with a deletion of residues 105-125

Journal

EMBO JOURNAL
Volume 26, Issue 2, Pages 548-558

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/sj.emboj.7601507

Keywords

lethal; prion; neurodegeneration; transgenic

Funding

  1. NINDS NIH HHS [NS04691003, NS040975, R01 NS040975, R01 NS035107, NS35107] Funding Source: Medline
  2. Telethon [TCR05006] Funding Source: Medline

Ask authors/readers for more resources

To identify sequence domains important for the neurotoxic and neuroprotective activities of the prion protein (PrP), we have engineered transgenic mice that express a form of murine PrP deleted for a conserved block of 21 amino acids (residues 105-125) in the unstructured, N-terminal tail of the protein. These mice spontaneously developed a severe neurodegenerative illness that was lethal within 1 week of birth in the absence of endogenous PrP. This phenotype was reversed in a dose-dependent fashion by coexpression of wild-type PrP, with five-fold overexpression delaying death beyond 1 year. The phenotype of Tg(PrP Delta 105-125) mice is reminiscent of, but much more severe than, those described in mice that express PrP harboring larger deletions of the N-terminus, and in mice that ectopically express Doppel, a PrP paralog, in the CNS. The dramatically increased toxicity of PrP Delta 105-125 is most consistent with a model in which this protein has greatly enhanced affinity for a hypothetical receptor that serves to transduce the toxic signal. We speculate that altered binding interactions involving the 105-125 region of PrP may also play a role in generating neurotoxic signals during prion infection.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available